Phase I clinical trial of a human idiotypic p53 vaccine in patients with advanced malignancy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/15/2/324/363300/mdh053.pdf
Reference33 articles.
1. Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen;Smith;Science,1994
2. Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies;Bartek;Oncogene,1991
3. Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form;Gannon;Embo J,1990
4. Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer;Crawford;Int J Cancer,1982
5. Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancers;Angelopoulou;Int J Cancer,1994
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Fueling Cancer Vaccines to Improve T Cell-Mediated Antitumor Immunity;Frontiers in Oncology;2022-05-16
2. Clinical and Immunological Effects of p53-Targeting Vaccines;Frontiers in Cell and Developmental Biology;2021-11-03
3. Immunological and Clinical Effects of Vaccines Targeting p53-Overexpressing Malignancies;Journal of Biomedicine and Biotechnology;2011
4. Construction of a triple modified p53 containing DNA vaccine to enhance processing and presentation of the p53 antigen;Vaccine;2009-12
5. Recent Advances in Validating MDM2 as a Cancer Target;Anti-Cancer Agents in Medicinal Chemistry;2009-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3